ConocoPhillips (COP)

Total Liabilities

$58.91B

Quarterly · Period ending: · USD

COP logo

COP Total Liabilities

Latest reported$58.91B
COP Quarterly Total Liabilities ($12.40B → $58.91B)
High-resolution chart · PNG

COP total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ConocoPhillips Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
58,912,000,000
58,184,000,000
57,452,000,000
57,549,000,000
57,027,000,000
59,016,000,000
57,984,000,000
46,818,000,000
46,249,000,000
46,023,000,000
46,645,000,000
45,906,000,000
42,074,000,000
43,658,000,000
45,826,000,000
45,758,000,000
43,491,000,000
44,090,000,000
45,255,000,000
43,189,000,000
41,127,000,000
40,538,000,000
32,769,000,000
32,374,000,000
31,553,000,000
33,646,000,000
35,464,000,000
35,101,000,000
38,187,000,000
38,517,000,000
37,916,000,000
38,477,000,000
37,714,000,000
40,009,000,000
42,561,000,000
44,149,000,000
47,505,000,000
52,372,000,000
54,546,000,000
57,828,000,000
58,223,000,000
60,427,000,000
57,402,000,000
61,394,000,000
63,034,000,000
61,034,000,000
64,266,000,000
63,325,000,000
65,962,000,000
66,404,000,000
65,565,000,000
68,223,000,000
68,015,000,000
68,540,000,000
68,717,000,000
67,492,000,000
67,565,000,000
95,838,000,000
87,496,000,000
88,363,000,000
89,490,000,000
89,122,000,000
87,205,000,000
85,416,000,000
85,511,000,000
91,393,000,000
89,531,000,000
90,330,000,000
90,066,000,000
87,058,000,000
86,600,000,000
90,604,000,000
96,613,000,000
92,552,000,000
87,601,000,000
85,314,000,000
84,760,000,000
87,226,000,000
80,933,000,000
82,026,000,000
83,294,000,000
86,222,000,000
53,059,000,000
53,302,000,000
48,957,000,000
50,685,000,000
49,033,000,000
48,015,000,000
46,660,000,000
47,663,000,000
47,247,000,000
48,186,000,000
47,974,000,000
48,545,000,000
46,668,000,000
46,842,000,000
22,367,000,000
21,560,000,000
20,877,000,000
20,928,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.